Le Lézard
Classified in: Health
Subjects: PSF, STP, SCZ

Latex Safety Events Stretch Far Beyond Gloves


HARRISBURG, Pa., March 22, 2018 /PRNewswire-USNewswire/ -- Maintaining a latex-safe healthcare environment can be a challenge for healthcare facilities. Despite the decreasing incidence of latex allergies, the potential for significant patient harm remains.

Courtesy of Shutterstock

"The correlation between latex allergies and gloves has become so intertwined, that other threats in healthcare environments that exist for those who have a latex allergy can be overlooked," said Dr. Ellen S. Deutsch, medical director for the Pennsylvania Patient Safety Authority. "Reactions from latex allergies can be life threatening safety events; identifying products that contain latex and assessing the risk for patient harm is essential."   

Analysis of latex-related events reported to the Authority between 2014 and 2016 identified 616 events. Those 616 events consisted of 72 "near misses" (events that might have caused harm but did not reach the patient), 537 exposure events (breaches in latex precautions that reached the patient), and 7 Serious Events (events resulting in patient harm).

Latex indwelling catheters were the most common source of unintended latex exposure (75%, n= 408 of 544). An additional thirty-five unique latex containing products were mentioned in event narratives, most notably gloves, Penrose drains, and red rubber catheters. The majority of both exposure and near miss events occurred in perioperative care areas (57.1%, n= 352 of 616).

Event narratives revealed (1) a variety of contributing factors for latex exposure events and (2) success modes for prevention. Lack of communication, poor documentation, and ineffective product management all contributed to unintended latex exposure events. Conversely, success modes for prevention included thorough patient assessments, acute observation of missing allergy wristbands, and handoff communication.

"It can be exciting when risk reduction strategies regarding a complex patient safety challenge, such as latex allergies, have been successful," says Deutsch. We must be careful not to forget that risk reduction is not eradication; there is still a small, but significant population that remains at risk for patient harm."  

In the Authority's March 2018 Pennsylvania Patient Safety Advisory article, "Latex: A Lingering and Lurking Safety Risk," the Authority discusses latex allergy exposures and strategies for prevention. A standalone graphic further highlights the important factors in protecting patients with latex allergies.

Download the full article.

Also published in this Advisory:

For more information about the Authority, patient safety topics, Advisory articles, and safety tips for patients, please visit patientsafety.pa.gov.

The Authority's mission is to improve the quality of healthcare in Pennsylvania by collecting and analyzing patient safety information, developing solutions to patient safety issues, and sharing this information through education and collaboration. Its vision is safe healthcare for all patients.

Like the Authority on Facebook
Subscribe to the Authority on YouTube
Follow the Authority on Twitter
Connect with the Authority on LinkedIn

Pennsylvania Patient Safety Authority - Visual Abstract:  Sustaining Risk Reduction Strategies to Protect Patients with Latex Allergies

SOURCE Pennsylvania Patient Safety Authority


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: